
Sign up to save your podcasts
Or


Osteoporosis remains a significant health concern, with new screening and treatment guidelines aiming to improve prevention and care. This episode explores updated recommendations, the latest therapeutic options, and how medications for other conditions can impact bone health. Stay informed and ready to support your patients—tune in to learn how pharmacists can make a difference.
HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact
GUEST
Erin Raney, PharmD, BCPS, BC-ADM
Professor
Midwestern University College of Pharmacy, Glendale Campus
Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Explain the updated screening and treatment guidelines for osteoporosis and their implications for patient care.
2. Identify medications that affect bone health strategies for pharmacists to mitigate their impact on osteoporosis risk.
0.05 CEU/0.5 Hr
UAN: 0107-0000-25-088-H01-P
Initial release date: 4/7/2025
Expiration date: 4/7/2026
Additional CPE details can be found here.
Follow CEimpact on Social Media:
LinkedIn
Instagram
By CEimpact4.8
1717 ratings
Osteoporosis remains a significant health concern, with new screening and treatment guidelines aiming to improve prevention and care. This episode explores updated recommendations, the latest therapeutic options, and how medications for other conditions can impact bone health. Stay informed and ready to support your patients—tune in to learn how pharmacists can make a difference.
HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact
GUEST
Erin Raney, PharmD, BCPS, BC-ADM
Professor
Midwestern University College of Pharmacy, Glendale Campus
Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Explain the updated screening and treatment guidelines for osteoporosis and their implications for patient care.
2. Identify medications that affect bone health strategies for pharmacists to mitigate their impact on osteoporosis risk.
0.05 CEU/0.5 Hr
UAN: 0107-0000-25-088-H01-P
Initial release date: 4/7/2025
Expiration date: 4/7/2026
Additional CPE details can be found here.
Follow CEimpact on Social Media:
LinkedIn
Instagram

90,829 Listeners

32,338 Listeners

37,561 Listeners

174 Listeners

647 Listeners

3,376 Listeners

113,460 Listeners

57,076 Listeners

9,308 Listeners

6,471 Listeners

58,971 Listeners

1,592 Listeners

1,249 Listeners

12 Listeners

10,182 Listeners